Etripamil is a calcium channel blocker designed to be administered intranasally to treat episodes of PSVT in an at-home setting. The Food and Drug Administration (FDA) has accepted for review the New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback